Header Logo

Connection

LILY CHENG to Papillomavirus Vaccines

Back to Details
This is a "connection" page, showing publications LILY CHENG has written about Papillomavirus Vaccines.
LILY CHENG
Connection Strength
0.043
Papillomavirus Vaccines
  1. Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2023 02 01; 29(3):560-570.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.